Optimal Weight to Height Scaling Varies for Cancers

This article originally appeared here.
Share this content:
Optimal Weight to Height Scaling Varies for Cancers
Optimal Weight to Height Scaling Varies for Cancers

(HealthDay News) -- Optimal scaling of weight to height (W/Hx) may vary according to the cancer site, and differs from body mass index, according to a study published online Nov. 7 in the American Journal of Epidemiology.

Geoffrey C. Kabat, Ph.D., of the Albert Einstein College of Medicine in Bronx, N.Y., and colleagues conducted a study using data from the Canadian National Breast Cancer Screening Study from 1980 to 2000 involving 89,835 women to evaluate how scaling W/Hx influences the association with risk of 19 different types of cancer.

The researchers identified significant positive associations for W/Hx with postmenopausal breast cancer, endometrial cancer, kidney cancer, and lung cancer in never smokers, with x ranging from 0.8 (endometrial cancer) to 1.7 (postmenopausal breast cancer). In ever smokers, W/Hx correlated inversely with lung cancer, and the association was significant for all values of x.

"Further studies are needed to confirm and extend these findings in other, more diverse populations," the authors write. "Potential implications of our findings are that epidemiologists should consider using different weight-for-height scaling to examine the association of body size with risk of disease in different populations."


Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs